Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study

Table 1 Characteristics of patients, demographic parameters

Patient number	Sex	APACHE-II score	SAPS-II score	Main diagnosis	ICU survival	Cause of death
1	m	17	42	Cirrhosis of the liver	-	Pneumonia, sepsis
2	f	27	69	Pneumonia, sepsis	+
3	f	31	78	Erysipelas, sepsis	+
4	f	27	56	Liver failure	-	Pneumonia, sepsis
5	m	22	62	Intracerebral hemorrhage	+
6	f	33	73	Pneumonia, sepsis	-	Peritonitis, sepsis
7	m	34	77	Pneumonia, sepsis	+
8	f	17	44	Pneumonia, sepsis	+
9	f	34	79	Pneumonia, sepsis	-	Pneumonia, sepsis
10	f	40	74	Pulmonary embolism	-	Heart insufficiency
11	f	19	54	Retroperitoneal hemorrhage	+
12	m	19	30	Cirrhosis of the liver	+
	8 f/4 m	26.7 ± 7.8	61.5 ± 16.3		7+/5-

Showing sex (m, male; f, female), APACHE II score on ICU admission, SAPS-II score on the day of first argatroban administration, main diagnosis on ICU admission, ICU survival (+, survived; -, died), and cause of death. Data are provided for each patient as mean ± SD where possible. APACHE II, Acute Physiology and Chronic Health Evaluation II Score; ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score.

ISSN: 1364-8535